Rezolute
Redwood City, California, United States · Biotechnology, Biotechnology Research, Health Care
Rezolute is a late-stage rare disease company focused on significantly improving outcomes for individuals with hypoglycemia caused by hyperinsulinism (HI).
Key facts
- Headquarters
- Redwood City, California, United States
- Employees
- 64
- Industries
- Biotechnology, Biotechnology Research, Health Care
- Status
- Public (RZLT)
- Website
- antriabio.com
- Company page
Recent activity at Rezolute
- : SEC 8-K (2.02): On September 24, 2026, Rezolute, Inc. announced its financial results for the fourth quarter and fiscal year ended June 30, 2026. This press release provides crucial insights into the company's financial performance over the previous year, detailing revenues, expenses, net income, and other key financial metrics. The announcement is significant for investors and stakeholders as it reflects the company's financial health and strategic direction moving forward. The document attached as Exhibit 99.1 likely includes comprehensive financial statements and management's discussion regarding the results. This filing can impact stock performance and investor sentiment.
- : SEC 8-K (5.07): On November 19, 2025, Rezolute, Inc. held its 2026 annual meeting of stockholders virtually. As of the record date, September 22, 2025, there were 90,811,368 shares outstanding, with 66,700,068 shares represented at the meeting, constituting a quorum. The primary item discussed was the election of directors, with Nevan Charles Elam receiving 59,206,610 votes in favor and 161,306 votes withheld. This meeting reflects the company's continued governance and strategic oversight as it prepares for the upcoming fiscal year, illustrating active shareholder engagement.
- : SEC 8-K (5.02): On October 17, 2025, Rezolute, Inc. amended the employment agreements of key executives including Nevan C. Elam (CEO), Brian Roberts (CMO), Daron Evans (CFO), and Sunil Karnawat (CCO). The amendments provide for a gross-up payment to cover any excise taxes and other tax obligations arising from excess parachute payments tied to any change of control events, consistent with Section 280G of the Internal Revenue Code. This adjustment implies significant tax considerations for executives in a change of control context, potentially influencing company strategy in mergers or acquisitions.
- : Rezolute Appoints Sunil Karnawat as Chief Commercial Officer
- : Rezolute Expands Leadership Team with Appointment of Daron Evans, MS, MBA, as Chief Financial Officer
- : Rezolute, Inc.
- : Rezolute, Inc.
- : Rezolute, Inc.
- : Rezolute, Inc.
- : AntriaBio, Inc.
Rezolute funding history
| Date | Round | Amount |
|---|---|---|
| Oct 2020 | Venture | $41.0M |
| Apr 2018 | Seed | $4.8M |
| Feb 2018 | Seed | $500K |
| Jan 2018 | Seed | $138K |
| May 2017 | Venture | $6.7M |
Leadership
- Nevan Elam, Executive Officer, Director
- Gil Labrucherie, Director
- Philippe Fauchet, Director
- Jung-Hee Lim, Director
- Young-Jin Kim, Director
- Gil Labrucherie, Director
- Samir Patel, Director
- David Welch, Director
- Tae Kim, Director
- Hoyoung Huh, Executive Officer, Director
- Nevan Elam, Executive Officer, Director
- Gil Labrucherie, Director
Verified email and direct lines for Rezolute’s decision-makers are on Fundz. See plans
Companies similar to Rezolute
- Altimmune · Biotechnology, Health Care, research, Therapeutics
- Applied StemCell · Biotechnology, Health Care, research, Therapeutics
- Takis S.r.l · Biotechnology, Health Care, research, Therapeutics
- AAVantgarde Bio · Biotechnology, Health Care, research, Therapeutics
- Corner Therapeutics · Biotechnology, Health Care, research, Therapeutics
About Rezolute: questions and answers
What does Rezolute do?
Rezolute is a late-stage rare disease company focused on significantly improving outcomes for individuals with hypoglycemia caused by hyperinsulinism (HI).
Where is Rezolute headquartered?
Rezolute is headquartered in Redwood City, California, United States.
How many employees does Rezolute have?
Rezolute has about 64 employees.
Has Rezolute raised funding?
Yes. Fundz has recorded 5 funding events for Rezolute. The most recent, $41.0M, was in Oct 2020.
What is the latest news on Rezolute?
On Sep 24, 2026, SEC 8-K (2.02): On September 24, 2026, Rezolute, Inc. announced its financial results for the fourth quarter and fiscal year ended June 30, 2026. This press release provides crucial insights into the company's financial performance over the previous year, detailing revenues, expenses, net income, an
Is Rezolute a public company?
Yes. Rezolute is publicly traded under the ticker RZLT.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy